ArticleScientific reports2026
A two-stage deep learning framework for kidney disease detection using modified specular-free imaging and EfficientNetB2.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney diseases represent a substantial public health concern, with their incidence increasing markedly over the past decade. Addressing this challenge, our research introduces a sophisticated two-stage diagnostic model for enhancing the detection accuracy of various kidney pathologies. The initial stage of the proposed model comprises a novel Modified Specular-Free (MSF) technique designed to improve the visual quality of renal images. This technique adaptively enhances image details by applying targeted enhancements for more discrimination between dark and bright luminance levels. The objective of this technique is to restore critical image information and enrich color representation in diagnostically-significant areas. The enhanced images are then processed through the second stage, which involves classification using the EfficientNet-B2 deep learning architecture. Our model was rigorously compared against a suite of established pre-trained models, including VGG16, ResNet50, VGG19, DenseNet121, DenseNet169, DenseNet201, EfficientNet-B0, EfficientNet-B1, and EfficientNet-B3. Comprehensive testing revealed that our model not only outperforms these benchmarks, but does so with a notable accuracy of 98.27%. The robustness of the model was further ensured through its capability to effectively differentiate between normal renal conditions and various pathologies such as tumors, kidney stones, and cysts. This research not only demonstrates the potential of integrating advanced image enhancement techniques with cutting-edge classification models but also introduces a scalable approach for improving diagnostic accuracies in other complex medical imaging contexts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.